Exit Interviews Reveal What Patients Really Felt About Tirzepatide and Dulaglutide
Exit interviews with 74 long-term participants in the SURPASS-CVOT trial reveal that tirzepatide and dulaglutide produced perceived benefits in glycemic ...
Tag: long-term patient perspectives on glucose-lowering medications
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!